5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.67%
Negative revenue growth while UPM.HE stands at 7.43%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-79.85%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
59.38%
Positive EBIT growth while UPM.HE is negative. John Neff might see a substantial edge in operational management.
59.38%
Positive operating income growth while UPM.HE is negative. John Neff might view this as a competitive edge in operations.
44.07%
Positive net income growth while UPM.HE is negative. John Neff might see a big relative performance advantage.
35.29%
Positive EPS growth while UPM.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
35.29%
Positive diluted EPS growth while UPM.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-13.56%
Share reduction while UPM.HE is at 1.08%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-13.56%
Reduced diluted shares while UPM.HE is at 0.64%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
5.88%
OCF growth above 1.5x UPM.HE's 1.79%. David Dodd would confirm a clear edge in underlying cash generation.
107.14%
Positive FCF growth while UPM.HE is negative. John Neff would see a strong competitive edge in net cash generation.
5.21%
Positive 10Y revenue/share CAGR while UPM.HE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
5.21%
5Y revenue/share CAGR 1.25-1.5x UPM.HE's 3.98%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
5.21%
3Y revenue/share CAGR at 50-75% of UPM.HE's 8.16%. Martin Whitman would question if the firm lags behind competitor innovations.
-71.64%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-71.64%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-71.64%
Negative 3Y OCF/share CAGR while UPM.HE stands at 61.12%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
54.17%
Positive 10Y CAGR while UPM.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
54.17%
Positive 5Y CAGR while UPM.HE is negative. John Neff might view this as a strong mid-term relative advantage.
54.17%
Positive short-term CAGR while UPM.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.39%
Inventory shrinking or stable vs. UPM.HE's 11.74%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
0.21%
Asset growth well under 50% of UPM.HE's 10.80%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
11.60%
Positive BV/share change while UPM.HE is negative. John Neff sees a clear edge over a competitor losing equity.
3.40%
Debt shrinking faster vs. UPM.HE's 22.72%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.